[Combined action of benzidine and 2-naphthylamine].
D000236:Adenoma / Q000139:chemically induced; D002759:Adenoma, Bile Duct / Q000139:chemically induced; D000588:Amines / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001560:Benzidines / Q000008:administration & dosage / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002273:Carcinogens / Q000494:pharmacology; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D004357:Drug Synergism; D005260:Female; D007279:Injections, Subcutaneous; D007414:Intestinal Neoplasms / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D008206:Lymphatic Diseases / Q000139:chemically induced; D008297:Male; D009284:Naphthols / Q000008:administration & dosage / Q000494:pharmacology*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced; D051381:Rats; D013997:Time Factors
D000588:Amines; D001560:Benzidines; D001713:Biphenyl Compounds; D002273:Carcinogens; D009284:Naphthols
O kombinirovannom deĭstvii benzidina i 2-naftilamina